Is there a problem with inhaled corticosteroid use in COPD?

J. Chalmers (Dundee (Angus), United Kingdom)

Source: Virtual Congress 2020 – Airway diseases
Session: Airway diseases
Session type: State of the art session
Number: 4514
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Chalmers (Dundee (Angus), United Kingdom). Is there a problem with inhaled corticosteroid use in COPD?. Virtual Congress 2020 – Airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014


Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Are inhaled corticosteroids increasing the “load” for some patients with COPD?
Source: Eur Respir J, 50 (4) 1701848; 10.1183/13993003.01848-2017
Year: 2017



Knowing when to stop: inhaled corticosteroids and COPD
Source: Eur Respir J 2015; 46: 1236-1238
Year: 2015


ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
Year: 2021


The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Inhaled corticosteroids in COPD: a case in favour
Source: Eur Respir J 2009; 34: 10-12
Year: 2009


Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005

The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014


Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
Year: 2009


The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007


The effect of applying inhaled corticosteroids in treating cough variant asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002